Work Outsourced to Indian Biotech and Pharma Companies is Not Yet Significantly Innovative

Current Science, 102, 401-404, 2012

Posted: 1 Feb 2016 Last revised: 27 Feb 2016

See all articles by Sajna Soby

Sajna Soby

Institute of Bioinformatics and Applied Biotechnology

Muthukrishnakumar Kandasamy

Institute of Bioinformatics and Applied Biotechnology

Gayatri Saberwal

Institute of Bioinformatics and Applied Biotechnology

Date Written: February 10, 2012

Abstract

We have examined whether – for biomedical US patents – inventors listed as based in India actually did the work in India. If so, was this work outsourced? The answer is largely 'no'. This would suggest that the skills required for drug discovery are not being honed by this route.

(Article freely downloadable from the journal website.)

Keywords: Biotech industry, pharma industry, innovation, outsourcing, patents

JEL Classification: H51, I10, L00, L33, L65, O31, O32, O33, O34, O51, O53

Suggested Citation

Soby, Sajna and Kandasamy, Muthukrishnakumar and Saberwal, Gayatri, Work Outsourced to Indian Biotech and Pharma Companies is Not Yet Significantly Innovative (February 10, 2012). Current Science, 102, 401-404, 2012, Available at SSRN: https://ssrn.com/abstract=2724520

Sajna Soby

Institute of Bioinformatics and Applied Biotechnology ( email )

Biotech Park
Electronics City Phase 1
Bengaluru, Karnataka 560100
India

Muthukrishnakumar Kandasamy

Institute of Bioinformatics and Applied Biotechnology ( email )

Biotech Park
Electronics City Phase 1
Bengaluru, Karnataka 560100
India

Gayatri Saberwal (Contact Author)

Institute of Bioinformatics and Applied Biotechnology ( email )

Biotech Park
Electronics City Phase 1
Bengaluru, Karnataka 560100
India

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Abstract Views
235
PlumX Metrics